Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
Cerebral Amyloid Imaging Using Florbetapir (AV-45) (IDEA3)

This study is aimed at examining the interest of amyloid radiotracer Florbetapir (18F-AV-45) for the etiological diagnosis of poststroke cognitive impairment and dementia

amyloid
18f-av-45
dementia
amyloidosis
cognitive impairment
  • 3 views
  • 24 Jan, 2022
  • 1 location
A Multicenter Study on the Diagnosis and Intervention of New Biomarkers on the Prodromal Stage of Alzheimer's Disease

National Institute of Aging and the Alzheimer's Disease Association (NIA-AA) diagnostic criteria in 2011. [18F]-AV-45 plaque imaging is used to be golden criteria for the diagnosis of AD and MCI due to AD

amyloid
early diagnosis
alzheimer's disease
cognitive impairment
Accepts healthy volunteers
  • 0 views
  • 24 Jan, 2022
The Influence of Vascular Burden Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With Tauopathy

atrophy, and SUVRs of [18F]AV-45 and [18F]MNI-958(PMPBB3) PET, the study will be able to investigate the composite influence of cerebrovascular disease and neurodegenerative pathology on the trajectory of

Accepts healthy volunteers
  • 0 views
  • 10 Oct, 2021
  • 1 location
Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study

The investigators will conduct tau positron emission tomography (PET) scans on 125 adults using the radiopharmaceutical Flortaucipir F18 ([18F]AV-1451). This will allow the investigators to determine tau deposition across adults of different ages and assess the relationship of current tau burden to cognitive function and amyloid deposition collected over the …

amyloid
cognitive decline
alzheimer's disease
mental deterioration
oophorectomy
  • 73 views
  • 24 Jan, 2022
  • 1 location